@article{6e0b222df7264fc099b4238826a19389,
title = "First multicentre experience of SABR for lymph node and liver oligometastatic disease on the unity MR-Linac",
abstract = "The treatment of oligometastatic disease using MR guidance is an evolving field. Since August 2018 patients are treated on a 1.5 Tesla MR-Linac (MRL). We present current workflows and practice standards from seven institutions for the initial patients treated for lymph node and liver metastases.",
keywords = "(3–6): oligometastases, MOMENTUM, MR-guided radiotherapy, MR-Linac, SABR",
author = "\{On Behalf of the tumor site group for oligometastatic disease of the Elekta MR-Linac Consortium\} and Janssen, \{Tomas M.\} and Katharine Aitken and Filippo Alongi and Aisling Barry and Uffe Bernchou and Simon Boeke and Hall, \{William A.\} and Ali Hosni and Kroon, \{Petra S.\} and Marcel Nachbar and Hina Saeed and J{\"u}rgenliemk-Schulz, \{Ina M.\} and Tine Schytte and Verkooijen, \{Helena M.\} and Nowee, \{Marlies E.\}",
note = "Publisher Copyright: {\textcopyright} 2022 The Author(s)",
year = "2022",
month = jun,
doi = "10.1016/j.tipsro.2022.04.005",
language = "English",
volume = "22",
pages = "50--54",
journal = "Technical Innovations and Patient Support in Radiation Oncology",
issn = "2405-6324",
publisher = "Elsevier Ireland Ltd",
}
